Time-Restricted Eating With Exercise

NCT ID: NCT05486702

Last Updated: 2022-08-03

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

30 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-08-31

Study Completion Date

2023-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of the study is to determine if body composition differs between early time restricted eating (8-hour feeding period from 7 am to 3 pm) with exercise and late time restricted eating (8-hour feeding period from 3 pm to 11 pm) with exercise in overweight adults.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Time-restricted eating (TRE) is a hot trend in weight-loss diets. TRE can reduce cardio-metabolic risks, thereby lowering body weight, blood pressure, lipid profile, glucose, and inflammation. The most effective way for the overweight population to improve body composition is to incorporate TRE with exercise. However, there were only two TRE interventions in humans that included exercise, suggesting that the additive effect of TRE to exercise may be dependent on dietary timing. TRE can be divided into early TRE (eTRE) and late TRE (lTRE), depending on the time of day of the eating window. However, whether different TRE schedules with exercise can improve cardio-metabolic health is questionable. There have been no interventions of different TRE schedules with exercise. This study will be beneficial for determining which TRE schedule with exercise is efficacious to prevent cardio-metabolic disease.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Obesity

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Early Time Restricted Eating

8-hour eating period from 7 am to 3 pm with exercise

Group Type EXPERIMENTAL

Time Restricted Eating

Intervention Type OTHER

Time restricted eating (TRE) can be divided into early TRE (eTRE) and late TRE (lTRE), depending on the time of day of the eating window.

Late Time Restricted Eating

8-hour eating period from 3 pm to 11 pm with exercise

Group Type EXPERIMENTAL

Time Restricted Eating

Intervention Type OTHER

Time restricted eating (TRE) can be divided into early TRE (eTRE) and late TRE (lTRE), depending on the time of day of the eating window.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Time Restricted Eating

Time restricted eating (TRE) can be divided into early TRE (eTRE) and late TRE (lTRE), depending on the time of day of the eating window.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. are adults, aged between 18-30 years
2. are apparently healthy and physically inactive (defined as any form of physical activity performed \< 2 days per week)
3. are overweight (BMI 25-\<30 kg/m2)
4. are non-smokers
5. are free from the following chronic medical conditions: heart disease, arrhythmias, diabetes, thyroid disease, bleeding disorder, history of pulmonary disease, hypertension, hepatorenal disease, musculoskeletal disorder, neuromuscular/neurological disease, autoimmune disease, cancer, peptic ulcers, anemia, or chronic infection (HIV)
6. are free from the orthopedic conditions that would hinder physical activity
7. have not taken any heart, pulmonary, thyroid, anti-hyperlipidemic, hypoglycemic, anti-hypertensive, endocrinological (e.g, thyroid, insulin, etc), emotional/psychotropic (e.g,Prednisone, Ritalin, Adderall), neuromuscular/neurological, or androgenic medications(anabolic steroids)
8. have low risk for cardiovascular disease and with no contraindications to exercise as outlined by the American College of Sports Medicine (ACSM) will be included.

Exclusion Criteria

1. are younger than 18 years and older than 30 years.
2. have consumed any medication for chronic medical condition.
3. are participating in weight management programs.
4. have constrictions to exercise.
5. are currently exercising regularly (at least 2 days per week).
Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Georgia College and State University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Jinkyung Park

Assistant Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jinkyung Park, Dr.

Role: PRINCIPAL_INVESTIGATOR

Georgia College and State University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Exercise Science Laboratory

Milledgeville, Georgia, United States

Site Status RECRUITING

Clinical Research Laboratory

Syracuse, New York, United States

Site Status RECRUITING

Anatomical Laboratory

Wichita Falls, Texas, United States

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Jinkyung Park, Dr.

Role: CONTACT

478-445-3930

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Jinkyung Park, Dr.

Role: primary

478-445-3930

Joon Young Kim, Dr.

Role: primary

315-443-1411

Soon-mi Choi, Dr.

Role: primary

940-397-4956

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

FRG202132

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Timing of Meals for Weight Loss
NCT02204735 COMPLETED NA
Chronic Effect of Fasting
NCT03574103 RECRUITING NA
Circadian Time Restricted Eating
NCT05628012 RECRUITING NA